Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii
- 1 April 2018
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 51 (4) , 646-650
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R21AI107302, R01AI104895)
- National Science and Technology Development Agency of Thailand
- Faculty of Medicine, Prince of Songkla University
This publication has 19 references indexed in Scilit:
- Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistinActa Neurochirurgica, 2016
- Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin MethanesulfonateAntimicrobial Agents and Chemotherapy, 2012
- Healthcare-Associated Bacterial MeningitisCurrent Infectious Disease Reports, 2011
- Penetration of Colistin into Cerebrospinal FluidAntimicrobial Agents and Chemotherapy, 2009
- Management of meningitis due to antibiotic-resistant Acinetobacter speciesThe Lancet Infectious Diseases, 2009
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment OptionsClinical Infectious Diseases, 2008
- Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatmentsJournal of Antimicrobial Chemotherapy, 2008
- Treatment Options for??Multidrug-Resistant Acinetobacter SpeciesDrugs, 2008
- Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistanceJournal of Antimicrobial Chemotherapy, 2007
- Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature reviewJournal of Antimicrobial Chemotherapy, 2006